Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug Actos

Pharmaceutical companies Eli Lilly and Takeda are facing a class-action lawsuit over their diabetes drug Actos, which has been certified by a California Federal Judge. The case claims that the drug was marketed without disclosing its risk of bladder cancer, with plaintiffs alleging that both companies misled the FDA about Actos' mechanism to conceal aspects of the drug's safety profile. A Nation..